If Eric Lefkosky has anything to say about cancer, it has finally met its match. Lefkosky has started a new company called Tempus, which is determined to aid in the advance of cancer care and cures by implementing an innovative technique in data collection. Tempus seeks to take all of the data and other information that is currently being taken in by doctors and hospitals all over the world and streamlining it and making it easier to access.
Lefkosky was astonished at the lack of easy to access information on cancer care when his wife was diagnosed with breast cancer. He made it part of his life’s work to enhance what doctor’s, hospitals, and other healthcare practitioners have access to and how they can wield that information.
The company Tempus developed a proprietary software platform that can analyze clinical and molecular data and correlate it with pre-existing data. The problem, Eric Lefkofsky found, is that while doctors have access to large amounts of raw data, they had no real way to analyze it. This is why Tempus is on a mission to help solve this. They see both the value and the potential in the future of medical records that are easy to obtain and analyze.
Eric Lefkofsky is no stranger to high-tech solutions to real-world problems. He has been active being an entrepreneur since the late 1990s. Since then, he has been CEO or on the board of several cutting-edge companies. He and his wife joined The Giving Pledge. This is an organization that helps billionaires donate a large portion of their wealth to charitable causes either when they are alive or after they pass. They are also firm believers in other charitable causes and even started the Lefkosky Foundation, which helps to fund organizations of a scientific, charitable, or educational goal, with a special emphasis on children.